Latest Competition News

Page 350 of 370
Pioneer Lithium Limited has lifted its trading suspension following the announcement of a proposed material acquisition and capital raising, signaling a pivotal moment for the company’s growth strategy.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Element 25 Limited reports a transformative quarter with a 142% resource increase at Butcherbird, a compelling $561 million NPV feasibility study, and a $268 million US Department of Energy grant to advance its Louisiana battery-grade manganese refinery.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Almonty Industries has secured an exclusive offtake agreement with South Korea’s SeAH Group to supply 100% of molybdenum from its Sangdong project, underpinning financial stability and strengthening local supply chains.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Element 25 Limited has successfully raised AU$2.85 million through an at-the-market share placement with Acuity Capital, issuing 8.7 million shares at a premium price to bolster its working capital.
Maxwell Dee
Maxwell Dee
30 Jan 2025
FirstWave reports a stable Q2 FY25 with no cash burn for the second consecutive quarter, maintaining cash reserves at $1.68 million while securing key client contract renewals and launching a promising new product.
Sophie Babbage
Sophie Babbage
30 Jan 2025
Argenica Therapeutics has dosed 80% of patients in its Phase 2 stroke trial and gained FDA orphan drug designations for its second candidate, ARG-006. The company reports a cash-positive quarter with $15 million in reserves.
Ada Torres
Ada Torres
30 Jan 2025
OpenLearning Limited reported a 23% year-on-year increase in SaaS annual recurring revenue to $2.335 million in Q4 FY24, driven by strong growth in AI-powered products and strategic partnerships. The company also cut net operating cash outflows by over half, signaling improved operational efficiency.
Victor Sage
Victor Sage
30 Jan 2025
NEXION Group reported a robust 30% increase in cash receipts for Q2 FY25, driven by strong sales growth and new satellite sector contracts. The company is actively expanding its footprint in Southeast Asia while funding ongoing M&A activities through convertible notes.
Sophie Babbage
Sophie Babbage
30 Jan 2025
Argenica Therapeutics has received a positive safety review from its independent DSMB for the Phase 2 trial of ARG-007 in acute ischaemic stroke patients, with dosing now 86% complete and full recruitment expected by early Q2 2025.
Ada Torres
Ada Torres
30 Jan 2025
Syrah Resources faces significant operational disruption at its Balama graphite mine due to ongoing protests, declaring force majeure while advancing its US-based Vidalia facility amid strong EV market growth.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Appen's Q4 FY24 results reveal a robust 37% revenue increase excluding Google, alongside improved EBITDA profitability, driven by generative AI projects and strategic cost management.
Sophie Babbage
Sophie Babbage
30 Jan 2025
Cynata Therapeutics reports encouraging Phase 1 results for its diabetic foot ulcer treatment CYP-006TK, alongside a strengthened balance sheet and ongoing clinical progress.
Ada Torres
Ada Torres
30 Jan 2025